BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/9/2021 10:25:22 AM | Browse: 424 | Download: 919
 |
Received |
|
2020-12-27 11:07 |
|
Peer-Review Started |
|
2020-12-27 11:08 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-04-20 22:51 |
|
Revised |
|
2021-04-25 11:56 |
|
Second Decision |
|
2021-07-07 12:53 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2021-07-07 13:56 |
|
Articles in Press |
|
2021-07-07 13:56 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2021-07-14 18:58 |
|
Typeset the Manuscript |
|
2021-07-27 04:09 |
|
Publish the Manuscript Online |
|
2021-08-09 10:25 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Ophthalmology |
| Manuscript Type |
Minireviews |
| Article Title |
Place of intravitreal dexamethasone implant in the treatment armamentarium of diabetic macular edema
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Omer Karti and Ali Osman Saatci |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Ali Osman Saatci, MD, Professor, Department of Ophthalmology, Dokuz Eylul University, İnciraltı Mahallesi Mithatpaşa cad. No. 1606 Balçova, İzmir 35330, Türkiye. osman.saatci@yahoo.com |
| Key Words |
Dexamethasone implant; Diabetic macular edema; Diabetic retinopathy; Drug-delivery system; Glaucoma; Pharmacotherapy |
| Core Tip |
Administration of dexamethasone (DEX) implant is among the main therapeutic alternatives for treating the diabetic macular edema (DME). Though DEX implant provides a long-standing anatomic and visual improvement, implant induced cataract progression and intraocular pressure elevation limit its clinical use as the first-line treatment but DEX implant can sometimes be the preferred option in previously vitrectomized eyes, pseudophakic eyes, and in some specific conditions where the use of vascular endothelial growth factor inhibitors is either contraindicated or suboptimal. In this mini-review, we overviewed the randomized-controlled trials, real-life clinical experiences, and meta-analyses on DEX implant treatment in DME. |
| Publish Date |
2021-08-09 10:25 |
| Citation |
Karti O, Saatci AO. Place of intravitreal dexamethasone implant in the treatment armamentarium of diabetic macular edema. World J Diabetes 021; 12(8): 1220-1232 |
| URL |
https://www.wjgnet.com/1948-9358/full/v12/i8/1220.htm |
| DOI |
https://dx.doi.org/10.4239/wjd.v12.i8.1220 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
